Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Return on Invested Capital [ROIC] (2017 - 2020)

Updated

Emmaus Life Sciences (EMMA) reported Return on Invested Capital [ROIC] of -5.73% for Q4 2020.

Analysis

Emmaus Life Sciences (EMMA) Return on Invested Capital [ROIC] (2017 - 2020) Analysis & Trends

For FY2017, Emmaus Life Sciences posted Return on Invested Capital [ROIC] of -394.41%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -2.36%
Mar 31, 2020 -93.55%
Mar 31, 2018 -62.26%
Sep 30, 2017 -386.95%
Mar 31, 2017 -1,359.18%
API Access

Emmaus Life Sciences Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEY